From microscopy to computer tomography (CT) scans, imaging plays an important role in biological and biomedical research, but obtaining high-quality images often requires advanced technology and expertise, and can be costly.
Euro-BioImaging, a project which now launches its preparatory phase, aims to provide scientists throughout Europe with open access to state-of-the-art imaging technologies at all levels of biological and biomedical research, from bench to bedside. The project is part of the European Commission’s European Strategy Forum on Research Infrastructures (ESFRI) roadmap.
During the 3-year preparatory phase that starts today, Euro-BioImaging will develop a plan to construct and operate a set of complementary and strongly interlinked imaging infrastructure facilities. This plan will be based on a comprehensive assessment of researchers’ needs in terms of access, service, and training. Euro-BioImaging will also establish the legal, governmental and financial framework for such infrastructures, and seek agreements with funding bodies. Eligibility criteria for participating facilities will be defined, an independent evaluation panel will be established, and a call for applications will be announced.
“Euro-BioImaging will support research, training and innovation in biological and biomedical imaging on a pan-European level, by providing imaging services with an overarching strategic plan,” says Jan Ellenberg from the European Molecular Biology Laboratory (EMBL), scientific coordinator for biological imaging.
Euro-BioImaging aims to bring together key research areas, from basic biological imaging and molecular imaging to the clinical and epidemiological level of medical imaging. The project intends to address the current fragmentation of imaging infrastructure in Europe, by creating a coordinated and harmonised plan for its deployment throughout the continent. It will provide scientists in Europe with open access to state-of-the-art imaging technologies and training, continuously developing imaging technologies to offer cutting-edge services to the scientific community.
“Given the broad range of imaging technologies coordinated through Euro-BioImaging, the research infrastructure will facilitate the translation from basic results to medical applications,” says Stefan Schönberg from the University Medical Centre Mannheim, Medical Faculty Mannheim, scientific coordinator for biomedical imaging on behalf of the European Institute for Biomedical Imaging Research (EIBIR).
As one of the project’s aims is to keep Europe at the forefront of technological innovation in this area, commercial opportunities are expected to arise. To make the most of them when they do, Euro-BioImaging has already started to form an industry board in which all leading vendors and producers of biomedical imaging equipment in Europe are represented.
Policy regarding use
EMBL press and picture releases including photographs, graphics, movies and videos are copyrighted by EMBL unless otherwise stated. They may be freely reprinted and distributed for non-commercial use via print, broadcast and electronic media, provided that proper attribution to authors, photographers and designers is made.Sonia Furtado
Sonia Furtado | EMBL Research News
Closing the carbon loop
08.12.2016 | University of Pittsburgh
Newly discovered bacteria-binding protein in the intestine
08.12.2016 | University of Gothenburg
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
08.12.2016 | Life Sciences
08.12.2016 | Physics and Astronomy
08.12.2016 | Materials Sciences